Oppenheimer & Co’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DIAX
PPA
AAM
KIM
RJFSA
LTFS
Oppenheimer & Co's DIAX Position: Q1 2017 in Review
Oppenheimer & Co sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2017, closing a stake of 11,774 shares — an estimated $177K sold.
Oppenheimer & Co first reported a position in DIAX in Q4 2014 and held it in 7 quarters. The position peaked at $431K in Q1 2015. 62 funds tracked by Wall St. Rank hold DIAX as of Q1 2017.
- Oppenheimer & Co reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2017 after selling out during the quarter.
- Oppenheimer & Co sold 11,774 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2017, an estimated $177K.
- Oppenheimer & Co first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2014 and held it in 7 quarters.
- Oppenheimer & Co's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $431K in Q1 2015.
- 62 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2017.
Based on Oppenheimer & Co's 13F filing for Q1 2017, filed 15 May 2017.